BR112022003666A2 - Predição de evento de risco cardiovascular e usos da mesma - Google Patents

Predição de evento de risco cardiovascular e usos da mesma

Info

Publication number
BR112022003666A2
BR112022003666A2 BR112022003666A BR112022003666A BR112022003666A2 BR 112022003666 A2 BR112022003666 A2 BR 112022003666A2 BR 112022003666 A BR112022003666 A BR 112022003666A BR 112022003666 A BR112022003666 A BR 112022003666A BR 112022003666 A2 BR112022003666 A2 BR 112022003666A2
Authority
BR
Brazil
Prior art keywords
prediction
cardiovascular risk
risk event
cardiovascular
risk
Prior art date
Application number
BR112022003666A
Other languages
English (en)
Inventor
Gargi Datta
Michael Hinterberg
Original Assignee
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Operating Co Inc filed Critical Somalogic Operating Co Inc
Publication of BR112022003666A2 publication Critical patent/BR112022003666A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

predição de evento de risco cardiovascular e usos da mesma. a presente invenção refere-se a biomarcadores, métodos, dispositivos, reagentes, sistemas e kits usados para avaliar um indivíduo quanto a predição do risco de desenvolver um evento cardiovascular (cv) primário ou secundário durante um período de 4 anos.
BR112022003666A 2019-09-03 2020-09-02 Predição de evento de risco cardiovascular e usos da mesma BR112022003666A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962895383P 2019-09-03 2019-09-03
PCT/US2020/048981 WO2021046074A1 (en) 2019-09-03 2020-09-02 Cardiovascular risk event prediction and uses thereof

Publications (1)

Publication Number Publication Date
BR112022003666A2 true BR112022003666A2 (pt) 2022-05-24

Family

ID=72521733

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022003666A BR112022003666A2 (pt) 2019-09-03 2020-09-02 Predição de evento de risco cardiovascular e usos da mesma

Country Status (11)

Country Link
US (1) US20220349904A1 (pt)
EP (1) EP4025916A1 (pt)
JP (1) JP2022546515A (pt)
KR (1) KR20220057534A (pt)
CN (1) CN114641692A (pt)
AU (1) AU2020343243A1 (pt)
BR (1) BR112022003666A2 (pt)
CA (1) CA3151482A1 (pt)
IL (1) IL290951A (pt)
MX (1) MX2022002314A (pt)
WO (1) WO2021046074A1 (pt)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
ES2259800T3 (es) 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US6001577A (en) 1998-06-08 1999-12-14 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US6458539B1 (en) 1993-09-17 2002-10-01 Somalogic, Inc. Photoselection of nucleic acid ligands
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US8409795B2 (en) 2007-07-17 2013-04-02 Somalogic, Inc. Selex and photoSELEX
BR112012032537B8 (pt) 2010-07-09 2022-10-18 Somalogic Inc Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo
EP2622104A4 (en) 2010-09-27 2015-04-15 Somalogic Inc BIOMARKERS FOR MESOTHELIOMES AND USES THEREOF

Also Published As

Publication number Publication date
CA3151482A1 (en) 2021-03-11
EP4025916A1 (en) 2022-07-13
US20220349904A1 (en) 2022-11-03
KR20220057534A (ko) 2022-05-09
WO2021046074A1 (en) 2021-03-11
IL290951A (en) 2022-04-01
MX2022002314A (es) 2022-06-02
AU2020343243A1 (en) 2022-03-10
CN114641692A (zh) 2022-06-17
JP2022546515A (ja) 2022-11-04

Similar Documents

Publication Publication Date Title
BR102019009695B8 (pt) Método realizado por um sistema de controle para uma máquina de trabalho, e, sistema de computação
BR112014007214A8 (pt) Método para determinar a probabilidade de que um indivíduo tenha risco elevado de um evento cardiovascular, método para avaliação do risco de um evento cardiovascular futuro e método implementado por computador para avaliação do risco de um evento cardiovascular
BR112019000742A2 (pt) método e kit para analisar uma amostra
CO2019000939A2 (es) Transmisión inicial mejorada y retransmisiones de datos para transmisiones v2x
BR112020009271A8 (pt) Aparelho terminal, aparelho de estação-base, método de comunicação e circuito integrado
EA201791578A1 (ru) Панель биомаркеров для обнаружения рака
BR112022007638A2 (pt) Método e dispositivo de ajuste rlm e/ou de ajuste bfd.
BR112018003372A2 (pt) método para fornecer recomendações de barbeamento em estágios, programa de computador executável em uma unidade de processamento, sistema de cuidados pessoais, e aparelho de barbeamento
BR112022018981A2 (pt) Descoberta eficiente de servidores de computação de borda
BR112019002410A2 (pt) método de transmissão de dados de serviço, dispositivo de rede, dispositivo terminal, sistema e meio legível por computador
BR112022026875A2 (pt) Habilitação de âncoras de posicionamento do equipamento de usuário (ue) para posicionamento de veículo-para-tudo (v2x), veículo-para-veículo (v2v) e veículo-para-pedestre (v2p)
BR112017009025A2 (pt) métodos para calibrar dispositivos de computação óptica ou sensores ópticos.
BR112019022986A2 (pt) método de transmissão de informações de controle, e dispositivo, meio de armazenamento legível por computador e programa de computador
BR112018003775A2 (pt) método e aparelho de gerenciamento de recursos
BR112023004305A2 (pt) Configuração e gerenciamento de sinal de referência de posicionamento
BR112017019895A2 (pt) tira ou folha de metal, placa, placa bipolar e método para a fabricação de uma tira ou folha de metal
BR112022003666A2 (pt) Predição de evento de risco cardiovascular e usos da mesma
PH12020551481A1 (en) Operation support system and operation support method for desulfurization apparatus
BR112019025008A2 (pt) Material de gravação contendo um formador de cor, folha de gravação, método para usar pelo menos um composto, e, composto.
BR112022005168A2 (pt) Método realizado por um dispositivo terminal, dispositivo terminal, e, produto de programa de computador
BR112016017901A2 (pt) ensaio inovador para detectar periostina humana
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
BR112019007138A2 (pt) método e sistema de análise para testagem de uma amostra
BR112021019316A2 (pt) Terminal de usuário e método de radiocomunicação
BR112022019266A2 (pt) Método para detectar analitos de abundância variável